glp 1 for 20 lb weight loss Woman, 32, Credits GLP-1 with Helping Her Stop Eating Noodle Sandwiches 2 MONTHS ON SEMAGLUTIDE *GLP-1*

Summary: GLP-1 receptor agonists are prescription medications that may support weight management during perimenopause by suppressing appetite and delaying gastric emptying, but they are not specifically indicated for hormonal changes and require strict NHS eligibility criteria

At higher doses, the same GH-related effects seen with CJC-1295 (water retention, joint stiffness) may appear but are typically mild

[2] Additionally, findings from SURPASS-1 and SURPASS-2 highlight the importance of gradual dose increases to improve patient adherence and reduce dropouts

Would you like a signed copy of the book, with a personal message

Brighten breaks down how perimenopause and menopause shift insulin sensitivity, fat distribution, appetite, and recovery and where glucagon-like peptide-1 (GLP-1) receptor agonists (think semaglutide/Ozempic, Wegovy, liraglutide, tirzepatide as a related incretin therapy) can fit safely alongside hormone therapy, lifting, protein, and smart lab work

But success brings its own challenges